The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Candidiasis, Oral

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Candidiasis, Oral


High impact information on Candidiasis, Oral


Chemical compound and disease context of Candidiasis, Oral


Biological context of Candidiasis, Oral


Anatomical context of Candidiasis, Oral


Gene context of Candidiasis, Oral

  • In summary, MUC7 12-mer peptides appear to be excellent candidates for investigation of antifungal activity in in vivo models of oral candidiasis [23].
  • If C. albicans uses MMPs (mainly MMP-9) to disseminate, inhibition of this protease could be of interest in treating a variety of inflammatory disorders, including oral candidiasis [24].
  • The results support previous conclusions that IL-4 is associated with resistance to oral candidiasis and suggest that NO is involved in controlling colonization of the oral mucosal surface with C. albicans [25].
  • Antifungal activity of human salivary mucin-derived peptide, MUC7 12-mer, in a murine model of oral candidiasis [26].
  • The rationale of this study was to investigate the involvement of IL-18 in the inflammatory response against oral candidiasis [27].

Analytical, diagnostic and therapeutic context of Candidiasis, Oral


  1. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. Selwyn, P.A., Alcabes, P., Hartel, D., Buono, D., Schoenbaum, E.E., Klein, R.S., Davenny, K., Friedland, G.H. N. Engl. J. Med. (1992) [Pubmed]
  2. Experimental oral candidiasis in animal models. Samaranayake, Y.H., Samaranayake, L.P. Clin. Microbiol. Rev. (2001) [Pubmed]
  3. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. Fichtenbaum, C.J., Zackin, R., Rajicic, N., Powderly, W.G., Wheat, L.J., Zingman, B.S. AIDS (2000) [Pubmed]
  4. Clotrimazole treatment of oral candidiasis in patients with neoplastic disease. Shechtman, L.B., Funaro, L., Robin, T., Bottone, E.J., Cuttner, J. Am. J. Med. (1984) [Pubmed]
  5. Placebo-controlled trial of prednisone in advanced HIV-1 infection. McComsey, G.A., Whalen, C.C., Mawhorter, S.D., Asaad, R., Valdez, H., Patki, A.H., Klaumunzner, J., Gopalakrishna, K.V., Calabrese, L.H., Lederman, M.M. AIDS (2001) [Pubmed]
  6. Treatment of chronic oral candidiasis with clotrimazole troches. A controlled clinical trial. Kirkpatrick, C.H., Alling, D.W. N. Engl. J. Med. (1978) [Pubmed]
  7. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. Hughes, W.T., Kuhn, S., Chaudhary, S., Feldman, S., Verzosa, M., Aur, R.J., Pratt, C., George, S.L. N. Engl. J. Med. (1977) [Pubmed]
  8. Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme. Masci, J.R. AIDS (2000) [Pubmed]
  9. Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension. Moshi, A.H., Jorgensen, A.F., Pallangyo, K. AIDS (1998) [Pubmed]
  10. Treatment of mycoses in cancer patients. Meunier-Carpentier, F. Am. J. Med. (1983) [Pubmed]
  11. Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans. Nguyen, M.T., Weiss, P.J., LaBarre, R.C., Miller, L.K., Oldfield, E.C., Wallace, M.R. AIDS (1996) [Pubmed]
  12. A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis. De Wit, S., Dupont, B., Cartledge, J.D., Hawkins, D.A., Gazzard, B.G., Clumeck, N., Denning, D.W. AIDS (1997) [Pubmed]
  13. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. Condemi, J.J., Chervinsky, P., Goldstein, M.F., Ford, L.B., Berger, W.E., Ayars, G.H., Rogenes, P.R., Edwards, L., Pepsin, P.J. J. Allergy Clin. Immunol. (1997) [Pubmed]
  14. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. Chavanet, P., Lopez, J., Grappin, M., Bonnin, A., Duong, M., Waldner, A., Buisson, M., Camerlynck, P., Portier, H. AIDS (1994) [Pubmed]
  15. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Sangeorzan, J.A., Bradley, S.F., He, X., Zarins, L.T., Ridenour, G.L., Tiballi, R.N., Kauffman, C.A. Am. J. Med. (1994) [Pubmed]
  16. Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis. Reynes, J., Bazin, C., Ajana, F., Datry, A., Le Moing, J.P., Chwetzoff, E., Levron, J.C. Antimicrob. Agents Chemother. (1997) [Pubmed]
  17. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T., Michel-Briand, Y. J. Clin. Microbiol. (1994) [Pubmed]
  18. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. Tavanti, A., Pardini, G., Campa, D., Davini, P., Lupetti, A., Senesi, S. J. Clin. Microbiol. (2004) [Pubmed]
  19. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. Pincus, D.J., Szefler, S.J., Ackerson, L.M., Martin, R.J. J. Allergy Clin. Immunol. (1995) [Pubmed]
  20. CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Marquis, M., Lewandowski, D., Dugas, V., Aumont, F., Sénéchal, S., Jolicoeur, P., Hanna, Z., de Repentigny, L. Infect. Immun. (2006) [Pubmed]
  21. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S. J. Med. Microbiol. (2004) [Pubmed]
  22. Interventions for treating oral candidiasis for patients with cancer receiving treatment. Clarkson, J.E., Worthington, H.V., Eden, O.B. Cochrane database of systematic reviews (Online) (2002) [Pubmed]
  23. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells. Wei, G.X., Bobek, L.A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  24. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Claveau, I., Mostefaoui, Y., Rouabhia, M. Matrix Biol. (2004) [Pubmed]
  25. Nitric oxide-enhanced resistance to oral candidiasis. Elahi, S., Pang, G., Ashman, R.B., Clancy, R. Immunology (2001) [Pubmed]
  26. Antifungal activity of human salivary mucin-derived peptide, MUC7 12-mer, in a murine model of oral candidiasis. Muralidharan, R., Bobek, L.A. J. Pept. Res. (2005) [Pubmed]
  27. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis. Tardif, F., Goulet, J.P., Zakrazewski, A., Chauvin, P., Rouabhia, M. Med. Sci. Monit. (2004) [Pubmed]
  28. Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Avilés, A. Am. J. Med. (1987) [Pubmed]
  29. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Ferretti, G.A., Ash, R.C., Brown, A.T., Parr, M.D., Romond, E.H., Lillich, T.T. Bone Marrow Transplant. (1988) [Pubmed]
  30. Rapid mucosal absorption of topical lidocaine during bronchoscopy in the presence of oral candidiasis. Ameer, B., Burlingame, M.B., Harman, E.M. Chest (1989) [Pubmed]
  31. Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient. Takasuka, T., Baily, G.G., Birch, M., Anderson, M.J., Law, D., Denning, D.W. J. Infect. (1998) [Pubmed]
  32. Oral candidiasis and nutritional deficiencies in elderly hospitalised patients. Paillaud, E., Merlier, I., Dupeyron, C., Scherman, E., Poupon, J., Bories, P.N. Br. J. Nutr. (2004) [Pubmed]
WikiGenes - Universities